FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159370898> ?p ?o ?g. }

• W3159370898 abstract "Abstract Background Benzodiazepines (BZDs) and Z-drugs have high potential for developing frequent adverse drug events in older adults (e.g., psychomotor sedation, drug-related dementia, deliria, drug dependence, etc.). Knowledge of the prevalence and patterns of the use of BZDs/Z-drugs in vulnerable older patients is important in order to prevent and reduce the burden caused by their drug-related complications. Our study focused on international comparisons of the prevalence, country-specific prescribing patterns and risk factors of regular BZD/Z-drug use in nursing home (NH) residents. Methods This cross-sectional study retrospectively analysed data of 4156 NH residents, prospectively assessed in the Services and Health in the Elderly in Long TERm care (SHELTER) project conducted from 2009 to 2014. Residents aged 65+ in 57 NHs in 7 European countries and Israel were assessed by the InterRAI Long-Term Care Facilities instrument. Descriptive statistics and multiple logistic regression models were used to describe the country-specific prevalence, patterns and risk factors of BZD/Z-drug use. Results The mean age of the participants was 83.4 ± 9.4 years, 73% were female and 27.7% used BZDs/Z-drugs. The prevalence of BZD/Z-drug use differed significantly across countries, ranging from 44.1% in Israel to 14.5% in Germany. The most frequently prescribed were zopiclone (17.8%), lorazepam (17.1%) and oxazepam (16.3%). Lorazepam, oxazepam and diazepam were used in most of the countries. Brotizolam, temazepam and zolpidem showed highest prevalence in Israel (99.4% of all regular users of this medication in the sample), the Netherlands (72.6%) and France (50.0%), respectively. Residing in Israel was the most significant factor associated with the use of BZDs/Z-drugs or BZDs only (odds ratio [OR] 6.7; 95% confidence interval [CI] 4.8–9.2 and OR 9.7, 95%CI 6.5–14.5, respectively). The use of Z-drugs only was most significantly associated with residing in France (OR 21.0, 95%CI 9.0–48.9). Conclusions Despite global recommendations and warnings, the preference for and extent of use of individual BZDs and Z-drugs in vulnerable NH residents differ significantly across countries. The strong association with country of residence compared to clinical and functional factors denotes that prescribing habits, social, cultural, behavioural, and regulatory factors still play an important role in the current diverse use of these medications." @default.
• W3159370898 created "2021-05-10" @default.
• W3159370898 creator A5001426580 @default.
• W3159370898 creator A5027863323 @default.
• W3159370898 creator A5029055854 @default.
• W3159370898 creator A5037200438 @default.
• W3159370898 creator A5043527468 @default.
• W3159370898 creator A5044282024 @default.
• W3159370898 creator A5047119022 @default.
• W3159370898 creator A5054974510 @default.
• W3159370898 creator A5070343445 @default.
• W3159370898 creator A5084820846 @default.
• W3159370898 creator A5089145054 @default.
• W3159370898 date "2021-04-26" @default.
• W3159370898 modified "2023-10-17" @default.
• W3159370898 title "The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study" @default.
• W3159370898 cites W1845987094 @default.
• W3159370898 cites W1931878258 @default.
• W3159370898 cites W1969663483 @default.
• W3159370898 cites W1973348564 @default.
• W3159370898 cites W1987917214 @default.
• W3159370898 cites W2009014290 @default.
• W3159370898 cites W2013089513 @default.
• W3159370898 cites W2025140794 @default.
• W3159370898 cites W2038056264 @default.
• W3159370898 cites W2043524145 @default.
• W3159370898 cites W2056917744 @default.
• W3159370898 cites W2059765642 @default.
• W3159370898 cites W2063076497 @default.
• W3159370898 cites W2064052087 @default.
• W3159370898 cites W2084199942 @default.
• W3159370898 cites W2085924592 @default.
• W3159370898 cites W2093100182 @default.
• W3159370898 cites W2094113973 @default.
• W3159370898 cites W2096266503 @default.
• W3159370898 cites W2101264963 @default.
• W3159370898 cites W2101356989 @default.
• W3159370898 cites W2104213426 @default.
• W3159370898 cites W2105447009 @default.
• W3159370898 cites W2107981536 @default.
• W3159370898 cites W2113270760 @default.
• W3159370898 cites W2128349279 @default.
• W3159370898 cites W2139560403 @default.
• W3159370898 cites W2147969015 @default.
• W3159370898 cites W2151016127 @default.
• W3159370898 cites W2153607529 @default.
• W3159370898 cites W2160562969 @default.
• W3159370898 cites W2161393466 @default.
• W3159370898 cites W2169875489 @default.
• W3159370898 cites W2174713880 @default.
• W3159370898 cites W2183739768 @default.
• W3159370898 cites W2610505214 @default.
• W3159370898 cites W2883869784 @default.
• W3159370898 cites W2888171838 @default.
• W3159370898 cites W2939075034 @default.
• W3159370898 cites W2999939003 @default.
• W3159370898 cites W3009096924 @default.
• W3159370898 cites W3087235892 @default.
• W3159370898 cites W3097755530 @default.
• W3159370898 doi "https://doi.org/10.1186/s12877-021-02213-x" @default.
• W3159370898 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8077828" @default.
• W3159370898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33902474" @default.
• W3159370898 hasPublicationYear "2021" @default.
• W3159370898 type Work @default.
• W3159370898 sameAs 3159370898 @default.
• W3159370898 citedByCount "5" @default.
• W3159370898 countsByYear W31593708982022 @default.
• W3159370898 countsByYear W31593708982023 @default.
• W3159370898 crossrefType "journal-article" @default.
• W3159370898 hasAuthorship W3159370898A5001426580 @default.
• W3159370898 hasAuthorship W3159370898A5027863323 @default.
• W3159370898 hasAuthorship W3159370898A5029055854 @default.
• W3159370898 hasAuthorship W3159370898A5037200438 @default.
• W3159370898 hasAuthorship W3159370898A5043527468 @default.
• W3159370898 hasAuthorship W3159370898A5044282024 @default.
• W3159370898 hasAuthorship W3159370898A5047119022 @default.
• W3159370898 hasAuthorship W3159370898A5054974510 @default.
• W3159370898 hasAuthorship W3159370898A5070343445 @default.
• W3159370898 hasAuthorship W3159370898A5084820846 @default.
• W3159370898 hasAuthorship W3159370898A5089145054 @default.
• W3159370898 hasBestOaLocation W31593708981 @default.
• W3159370898 hasConcept C118552586 @default.
• W3159370898 hasConcept C126322002 @default.
• W3159370898 hasConcept C170493617 @default.
• W3159370898 hasConcept C2776615572 @default.
• W3159370898 hasConcept C2777810057 @default.
• W3159370898 hasConcept C2778173252 @default.
• W3159370898 hasConcept C2779706987 @default.
• W3159370898 hasConcept C2780233487 @default.
• W3159370898 hasConcept C2780930544 @default.
• W3159370898 hasConcept C2781006864 @default.
• W3159370898 hasConcept C71924100 @default.
• W3159370898 hasConceptScore W3159370898C118552586 @default.
• W3159370898 hasConceptScore W3159370898C126322002 @default.
• W3159370898 hasConceptScore W3159370898C170493617 @default.
• W3159370898 hasConceptScore W3159370898C2776615572 @default.
• W3159370898 hasConceptScore W3159370898C2777810057 @default.
• W3159370898 hasConceptScore W3159370898C2778173252 @default.
• W3159370898 hasConceptScore W3159370898C2779706987 @default.
• W3159370898 hasConceptScore W3159370898C2780233487 @default.

• next